Skip to main content

cetirizine

Generic: CETIRIZINE HYDROCHLORIDE·Brand: Aller-Tec, Aller-Tec D, Alleroff, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CHILDREN'S ZYRTEC ALLERGY, CHILDREN'S ZYRTEC HIVES, CHILDREN'S ZYRTEC HIVES RELIEF, QUZYTTIR, Quzyttir, Wal Zyr 24 Hour Allergy, Wal Zyr D, Wal-Zyr, ZERVIATE, ZYRTEC, ZYRTEC ALLERGY, ZYRTEC HIVES, Zerviate, Zyrtec, Zyrtec-D

cetirizine: developed by 2 companies · 2 clinical trials tracked · 2 FDA decisions.

cetirizine evidence translation

What we can confirm

2 FDA records · 2 tracked trials

What it means

More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about cetirizine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 2 study sponsors

Related indications

Uses Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
Development Pipeline (2)
CompanyPhase
DR REDDYS LABORATORIES LTD (RDY)Approved
Teva Pharmaceutical Industries Limited (TEVA)
Uses Temporarily relieves these symptoms due to hay fever or…
Approved
Clinical Trials (2)

A Study to Investigate Safety and Tolerability of Higher Infusion Rate to shORten the duraTion of FabrazymE Infusion

NCT06019728·Phase 4·SNY
Completed

Primary endpoint: Percent Reduction in Shortest Tolerated Infusion Duration From Pre-study Average of Recent 3 Infusions

Interventionalopen8 enrolledStarted 2023-11Completion 2024-105 sites · United StatesSanofi

A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ARC-520 at Varying Infusion Rates in Normal Adult Volunteers

NCT02535416·Phase 1·ARWR
Completed

Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (TEAEs)

Interventionalopen40 enrolledStarted 2015-09Completion 2016-081 site · AustraliaArrowhead Pharmaceuticals
FDA Decisions2 records
ApprovalUses Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat(TEVA)FDA ↗
ANDA077279OralSolution
ApprovalUses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: 1. runny nose 2. sneezing 3. itchy, watery eyes 4. itching of the nose or throat .(RDY)FDA ↗
ANDA078343OralTablet

Frequently asked questions

Who is developing cetirizine?

cetirizine is being developed by DR REDDYS LABORATORIES LTD, Teva Pharmaceutical Industries Limited.

How many clinical trials involve cetirizine?

BioSniper tracks 2 clinical trials involving cetirizine.

What is cetirizine's latest FDA decision?

The most recent tracked FDA decision for cetirizine is Approval for Uses Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat, dated May 27, 2008.